Multi-omics reveals new links between Fructosamine-3-Kinase (FN3K) and core metabolic pathways.


Journal

NPJ systems biology and applications
ISSN: 2056-7189
Titre abrégé: NPJ Syst Biol Appl
Pays: England
ID NLM: 101677786

Informations de publication

Date de publication:
03 Jun 2024
Historique:
received: 06 02 2024
accepted: 20 05 2024
medline: 4 6 2024
pubmed: 4 6 2024
entrez: 3 6 2024
Statut: epublish

Résumé

Fructosamine-3-kinases (FN3Ks) are a conserved family of repair enzymes that phosphorylate reactive sugars attached to lysine residues in peptides and proteins. Although FN3Ks are present across the Tree of Life and share detectable sequence similarity to eukaryotic protein kinases, the biological processes regulated by these kinases are largely unknown. To address this knowledge gap, we leveraged the FN3K CRISPR Knock-Out (KO) HepG2 cell line alongside an integrative multi-omics study combining transcriptomics, metabolomics, and interactomics to place these enzymes in a pathway context. The integrative analyses revealed the enrichment of pathways related to oxidative stress response, lipid biosynthesis (cholesterol and fatty acids), and carbon and co-factor metabolism. Moreover, enrichment of nicotinamide adenine dinucleotide (NAD) binding proteins and localization of human FN3K (HsFN3K) to mitochondria suggests potential links between FN3K and NAD-mediated energy metabolism and redox balance. We report specific binding of HsFN3K to NAD compounds in a metal and concentration-dependent manner and provide insight into their binding mode using modeling and experimental site-directed mutagenesis. Our studies provide a framework for targeting these understudied kinases in diabetic complications and metabolic disorders where redox balance and NAD-dependent metabolic processes are altered.

Identifiants

pubmed: 38830903
doi: 10.1038/s41540-024-00390-0
pii: 10.1038/s41540-024-00390-0
doi:

Substances chimiques

Phosphotransferases (Alcohol Group Acceptor) EC 2.7.1.-
fructosamine-3-kinase EC 2.7.1.-
NAD 0U46U6E8UK

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

64

Subventions

Organisme : U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
ID : 35 GM139656
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
ID : 35 GM139656
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
ID : 35 GM139656
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
ID : 35 GM139656

Informations de copyright

© 2024. The Author(s).

Références

Gkogkolou, P. & Böhm, M. Advanced glycation end products. Key players in skin aging? Derm.-Endocrinol. 4, 259–270 (2012).
doi: 10.4161/derm.22028
Uribarri, J. et al. Dietary advanced glycation end products and their role in health and disease. Adv. Nutr. 6, 461–473 (2015).
pubmed: 26178030 pmcid: 4496742 doi: 10.3945/an.115.008433
Baynes, J. W. et al. The Amadori product on protein: structure and reactions. Prog. Clin. Biol. Res. 304, 43–67 (1989).
pubmed: 2675036
Bommer, G. T., Van Schaftingen, E. & Veiga-da-Cunha, M. Metabolite repair enzymes control metabolic damage in glycolysis. Trends Biochem Sci. 45, 228–243 (2020).
pubmed: 31473074 doi: 10.1016/j.tibs.2019.07.004
Collard, F., Delpierre, G., Stroobant, V., Matthijs, G. & Van Schaftingen, E. A Mammalian Protein Homologous to Fructosamine-3-Kinase Acting on Psicosamines and Ribulosamines but not on Fructosamines. Diabetes 52, 2888–2895 (2003).
pubmed: 14633848 doi: 10.2337/diabetes.52.12.2888
Szwergold, B. S., Howell, S. & Beisswenger, P. J. Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo. Diabetes 50, 2139–2147 (2001).
pubmed: 11522682 doi: 10.2337/diabetes.50.9.2139
Alderawi, A. et al. FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease. BMJ Open Respir. Res. 7, https://doi.org/10.1136/bmjresp-2020-000714 (2020).
Dunmore, S. J. et al. Evidence that differences in fructosamine-3-kinase activity may be associated with the glycation gap in human diabetes. Diabetes 67, 131–136 (2018).
pubmed: 29066600 doi: 10.2337/db17-0441
Chen, J. H., Lin, X., Bu, C. & Zhang, X. Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies. Nutr. Metab. (Lond.) 15, 72 (2018).
pubmed: 30337945 doi: 10.1186/s12986-018-0306-7
Cepas, V., Collino, M., Mayo, J. C. & Sainz, R. M. Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases. Antioxidants (Basel) 9, https://doi.org/10.3390/antiox9020142 (2020).
Fortpied, J., Gemayel, R., Stroobant, V. & van Schaftingen, E. Plant ribulosamine/erythrulosamine 3-kinase, a putative protein-repair enzyme. Biochem. J. 388, 795–802 (2005).
pubmed: 15705060 pmcid: 1183458 doi: 10.1042/BJ20041976
Gemayel, R. et al. Many fructosamine 3kinase homologues in bacteria are ribulosamine/erythrulosamine 3-kinase potentially involved in protein deglycation. FEBS J. 274, 4360–4374 (2007).
pubmed: 17681011 doi: 10.1111/j.1742-4658.2007.05948.x
Cunningham, F. et al. Ensembl 2022. Nucleic Acids Res. 50, D988–d995 (2022).
pubmed: 34791404 doi: 10.1093/nar/gkab1049
Collard, F. et al. Fructosamine 3-kinase-related protein and deglycation in human erythrocytes. Biochem. J. 382, 137–143 (2004).
pubmed: 15137908 pmcid: 1133924 doi: 10.1042/BJ20040307
Thul, P. J. et al. A subcellular map of the human proteome. Science 356, eaal3321 (2017).
pubmed: 28495876 doi: 10.1126/science.aal3321
Shrestha, S. et al. A redox-active switch in fructosamine-3-kinases expands the regulatory repertoire of the protein kinase superfamily. Sci Signal 13, https://doi.org/10.1126/scisignal.aax6313 (2020).
Sanghvi, V. R. et al. The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase. Cell 178, 807–819.e821 (2019).
pubmed: 31398338 pmcid: 6693658 doi: 10.1016/j.cell.2019.07.031
Rushmore, T. H., Morton, M. R. & Pickett, C. B. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266, 11632–11639 (1991).
pubmed: 1646813 doi: 10.1016/S0021-9258(18)99004-6
McMahon, M., Itoh, K., Yamamoto, M. & Hayes, J. D. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem. 278, 21592–21600 (2003).
pubmed: 12682069 doi: 10.1074/jbc.M300931200
Avemaria, F. et al. Possible role of fructosamine 3-kinase genotyping fot the management of diabetic patients. Clin. Chem. Lab. Med. 53, 1315–1320 (2015).
pubmed: 26352355 doi: 10.1515/cclm-2015-0207
Avemaria, F. et al. Genetic variability of the fructosamine-3-kinase gene in diabetic patients. Clin. Chem. Lab. Med. 49, 803–808 (2011).
doi: 10.1515/CCLM.2011.133
Pertea, M., Kim, D., Pertea, G. M., Leek, J. T. & Salzberg, S. L. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat. Protoc. 11, 1650–1667 (2016).
pubmed: 27560171 pmcid: 5032908 doi: 10.1038/nprot.2016.095
Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907–915 (2019).
pubmed: 31375807 pmcid: 7605509 doi: 10.1038/s41587-019-0201-4
Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290–295, https://doi.org/10.1038/nbt.3122 .
Frazee, A. C. et al. Ballgown bridges the gap between transcriptome assembly and expression analysis. Nat. Biotechnol. 33, 243–246, https://doi.org/10.1038/nbt.3172 .
Dalmer, T. R. A. & Clugston, R. D. Gene ontology enrichment analysis of congenital diaphragmatic hernia-associated genes. Pediatric Res. 85, 13–19, https://doi.org/10.1038/s41390-018-0192-8 .
Si, M. & Lang, J. The roles of metallothioneins in carcinogenesis. J. Hematol. Onco.y 11, 107, https://doi.org/10.1186/s13045-018-0645-x .
Chong, J., Wishart, D. S. & Xia, J. Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis. Curr. Protocols Bioinform. 68, https://doi.org/10.1002/cpbi.86 (2019).
Utriainen, M. & Morris, J. H. clusterMaker2: a major update to clusterMaker, a multi-algorithm clustering app for Cytoscape. BMC Bioinforma. 24, 134 (2023).
doi: 10.1186/s12859-023-05225-z
Ellgaard, L. & Ruddock, L. W. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep. 6, 28–32 (2005).
pubmed: 15643448 pmcid: 1299221 doi: 10.1038/sj.embor.7400311
Jensen-Urstad, A. P. & Semenkovich, C. F. Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger? Biochimica et. biophysica acta 1821, 747–753 (2012).
pubmed: 22009142 doi: 10.1016/j.bbalip.2011.09.017
Quan, J., Bode, A. M. & Luo, X. ACSL family: The regulatory mechanisms and therapeutic implications in cancer. Eur. J. Pharmacol. 909, 174397 (2021).
pubmed: 34332918 doi: 10.1016/j.ejphar.2021.174397
Valvona, C. J., Fillmore, H. L., Nunn, P. B. & Pilkington, G. J. The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor. Brain Pathol. 26, 3–17 (2016).
pubmed: 26269128 doi: 10.1111/bpa.12299
Tang, Y. et al. Overexpression of PCK1 gene antagonizes hepatocellular carcinoma through the activation of gluconeogenesis and suppression of glycolysis pathways. Cell Physiol. Biochem. 47, 344–355 (2018).
pubmed: 29768256 doi: 10.1159/000489811
Xiao, W., Wang, R. S., Handy, D. E. & Loscalzo, J. NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism. Antioxid. Redox Signal 28, 251–272 (2018).
pubmed: 28648096 pmcid: 5737637 doi: 10.1089/ars.2017.7216
Harijan, R. K., Dalwani, S., Kiema, T. R., Venkatesan, R. & Wierenga, R. K. Thiolase: a versatile biocatalyst employing coenzyme A-thioester chemistry for making and breaking C-C bonds. Annu Rev. Biochem. 92, 351–384 (2023).
pubmed: 37068769 doi: 10.1146/annurev-biochem-052521-033746
Ruiz-Carmona, S. et al. rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids. PLoS Comput. Biol. 10, e1003571 (2014).
pubmed: 24722481 pmcid: 3983074 doi: 10.1371/journal.pcbi.1003571
Lu, C. H. et al. MIB2: metal ion-binding site prediction and modeling server. Bioinformatics 38, 4428–4429 (2022).
pubmed: 35904542 doi: 10.1093/bioinformatics/btac534
Šileikytė, J., Sundalam, S., David, L. L. & Cohen, M. S. Chemical Proteomics Approach for Profiling the NAD Interactome. J. Am. Chem. Soc. 143, 6787–6791 (2021).
pubmed: 33914500 pmcid: 10324298 doi: 10.1021/jacs.1c01302
Uhlén, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).
pubmed: 25613900 doi: 10.1126/science.1260419
Rafaeloff-Phail, R. et al. Biochemical regulation of mammalian AMP-activated protein kinase activity by NAD and NADH. J. Biol. Chem. 279, 52934–52939 (2004).
pubmed: 15465812 doi: 10.1074/jbc.M409574200
Del Toro, N. et al. The IntAct database: efficient access to fine-grained molecular interaction data. Nucleic Acids Res. 50, D648–d653 (2022).
pubmed: 34761267 doi: 10.1093/nar/gkab1006
Oughtred, R. et al. The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci. 30, 187–200 (2021).
pubmed: 33070389 doi: 10.1002/pro.3978
Berthiaume, J. M., Kurdys, J. G., Muntean, D. M. & Rosca, M. G. Mitochondrial NAD(+)/NADH Redox State and Diabetic Cardiomyopathy. Antioxid. Redox Signal 30, 375–398 (2019).
pubmed: 29073779 doi: 10.1089/ars.2017.7415
Calabrese, G., Morgan, B. & Riemer, J. Mitochondrial glutathione: regulation and functions. Antioxid. Redox Signal 27, 1162–1177 (2017).
pubmed: 28558477 doi: 10.1089/ars.2017.7121
Chung, H. S., Wang, S. B., Venkatraman, V., Murray, C. I. & Van Eyk, J. E. Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system. Circ. Res. 112, 382–392 (2013).
pubmed: 23329793 pmcid: 4340704 doi: 10.1161/CIRCRESAHA.112.268680
Xiao, H. et al. A quantitative tissue-specific landscape of protein redox regulation during aging. Cell 180, 968–983.e924 (2020).
pubmed: 32109415 pmcid: 8164166 doi: 10.1016/j.cell.2020.02.012
Alderawi, A. et al. FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease. https://doi.org/10.1136/bmjresp-2020-000714 .
Pertea, M., Kim, D., Pertea, G. M., Leek, J. T. & Salzberg, S. A.-O. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown.
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
pubmed: 14597658 pmcid: 403769 doi: 10.1101/gr.1239303
Doncheva, N. T., Morris, J. H., Gorodkin, J. & Jensen, L. J. Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data. J. Proteome Res. 18, 623–632 (2019).
pubmed: 30450911 doi: 10.1021/acs.jproteome.8b00702
Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).
pubmed: 10592173 pmcid: 102409 doi: 10.1093/nar/28.1.27
Gillespie, M. et al. The reactome pathway knowledgebase 2022. Nucleic Acids Res. 50, D687–d692 (2022).
pubmed: 34788843 doi: 10.1093/nar/gkab1028
Martens, M. et al. WikiPathways: connecting communities. Nucleic Acids Res. 49, D613–d621 (2021).
pubmed: 33211851 doi: 10.1093/nar/gkaa1024
Ashkenazy, H. et al. ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res. 44, W344–350, (2016).
pubmed: 27166375 pmcid: 4987940 doi: 10.1093/nar/gkw408
Pryor, P. R. Subcellular fractionation : a laboratory manual. (Cold Spring Harbor Laboratory Press, 2015).
Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401–404 (2012).
pubmed: 22588877 doi: 10.1158/2159-8290.CD-12-0095
Kutmon, M. et al. PathVisio 3: an extendable pathway analysis toolbox. PLoS Comput. Biol. 11, e1004085 (2015).
pubmed: 25706687 pmcid: 4338111 doi: 10.1371/journal.pcbi.1004085

Auteurs

Safal Shrestha (S)

Institute of Bioinformatics, University of Georgia, Athens, GA, USA.

Rahil Taujale (R)

Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, USA.

Samiksha Katiyar (S)

Institute of Bioinformatics, University of Georgia, Athens, GA, USA. samiksha@uga.edu.

Natarajan Kannan (N)

Institute of Bioinformatics, University of Georgia, Athens, GA, USA. nkannan@uga.edu.
Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, USA. nkannan@uga.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH